GTC BIOTHERAPEUTICS INC 4
4 · GTC BIOTHERAPEUTICS INC · Filed Feb 17, 2005
Insider Transaction Report
Form 4
MEADE HARRY
SVP, Transgenic Research
Transactions
- Award
Common Stock
2005-02-15+6,459→ 47,562 total - Award
Common Stock (right to buy)
2005-02-15+39,000→ 39,000 totalExercise: $1.71Exp: 2015-02-15→ Common Stock (39,000 underlying)
Holdings
- 10,486(indirect: By 401(k))
Common Stock
- 0(indirect: By Son)
Common Stock
Footnotes (3)
- [F1]Shares of the Issuer's common stock were awarded to the Reporting Person in lieu of a portion of what would otherwise have been cash bonus compensation for fiscal year 2004.
- [F2]The Reporting Person no longer has a reportable interest in shares of the Issuer's common stock owned by his son and included in the Reporting Person's prior ownership reports.
- [F3]7,800 options vested on February 15, 2005, the remaining 31,200 options vest in equal annual installments on each of February 15, 2006, 2007, 2008 and 2009.